JENNIFER HADLEY: Open Payments
NPI 1447645825 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$23,672 in 170 payments from 15 companies in 2025. Trend: 2023 $394 · 2024 $2,076 · 2025 $23,672
Honoraria: $15,950Food & beverage: $3,487Speaker / faculty: $3,150Travel & lodging: $1,085
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 26 | $17,594 |
| ABBVIE INC. | 30 | $3,623 |
| Vanda Pharmaceuticals Inc. | 21 | $561 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $466 |
| Alkermes, Inc. | 12 | $294 |
| Otsuka America Pharmaceutical, Inc. | 12 | $279 |
| Neurocrine BioSciences, Inc. | 9 | $195 |
| Corium, LLC | 8 | $166 |
| Teva Pharmaceuticals USA, Inc. | 12 | $157 |
| Tris Pharma Inc | 5 | $116 |
Products named: Auvelity, VRAYLAR, FANAPT, CAPLYTA, REXULTI, ARISTADA, INGREZZA, Azstarys.
Industry payments across AL — which companies pay providers there.
